Kappa-opioid receptors, dynorphin, and cocaine addiction: a positron emission tomography study

Neuropsychopharmacology. 2019 Sep;44(10):1720-1727. doi: 10.1038/s41386-019-0398-4. Epub 2019 Apr 26.

Abstract

Animal studies indicate that the kappa-opioid receptor/dynorphin system plays an important role in cocaine binges and stress-induced relapse. Our goal was to investigate changes in kappa-opioid receptor (KOR) availability in the human brain using positron emission tomography (PET), before and after a cocaine binge. We also investigated the correlation between KOR and stress-induced cocaine self-administration. PET imaging was performed with the KOR selective agonist [11C]GR103545. Subjects with cocaine-use disorder (CUD) underwent PET scans and performed two types of cocaine self-administration sessions in the laboratory as follows: (1) choice sessions following a cold pressor test, to induce stress, and (2) binge dosing of cocaine. This allowed us investigate the following: (1) the association between KOR binding and a laboratory model of stress-induced relapse and (2) the change in KOR binding following a 3-day cocaine binge, which is thought to represent a change in endogenous dynorphin. A group of matched healthy controls was included to investigate between group differences in KOR availability. A significant association between [11C]GR103545 binding and cocaine self-administration was seen: greater KOR availability was associated with more choices for cocaine. In addition, the 3-day cocaine binge significantly reduced [11C]GR103545 binding by 18% in the striatum and 14% across brain regions. No difference in [11C]GR103545 binding was found between the CUD subjects and matched controls. In the context of previous studies, these findings add to the growing evidence that pharmacotherapies targeting the KOR have the potential to significantly impact treatment development for cocaine-use disorder.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Brain / diagnostic imaging
  • Brain / metabolism*
  • Carbon Radioisotopes
  • Case-Control Studies
  • Choice Behavior
  • Cocaine / administration & dosage*
  • Cocaine Smoking
  • Cocaine-Related Disorders / diagnostic imaging
  • Cocaine-Related Disorders / metabolism*
  • Cocaine-Related Disorders / psychology
  • Dynorphins / metabolism
  • Humans
  • Male
  • Middle Aged
  • Naltrexone / pharmacology
  • Narcotic Antagonists / pharmacology
  • Neostriatum / diagnostic imaging
  • Neostriatum / metabolism
  • Piperazines
  • Positron-Emission Tomography
  • Pyrrolidines
  • Receptors, Opioid, kappa / metabolism*
  • Stress, Psychological / psychology

Substances

  • Carbon Radioisotopes
  • Narcotic Antagonists
  • OPRK1 protein, human
  • Piperazines
  • Pyrrolidines
  • Receptors, Opioid, kappa
  • GR 89696
  • Naltrexone
  • Dynorphins
  • Cocaine